1. Home
  2. OCUL vs SHOO Comparison

OCUL vs SHOO Comparison

Compare OCUL & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • SHOO
  • Stock Information
  • Founded
  • OCUL 2006
  • SHOO 1990
  • Country
  • OCUL United States
  • SHOO United States
  • Employees
  • OCUL N/A
  • SHOO N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • SHOO Shoe Manufacturing
  • Sector
  • OCUL Health Care
  • SHOO Consumer Discretionary
  • Exchange
  • OCUL Nasdaq
  • SHOO Nasdaq
  • Market Cap
  • OCUL 2.3B
  • SHOO 2.5B
  • IPO Year
  • OCUL 2014
  • SHOO 1993
  • Fundamental
  • Price
  • OCUL $11.26
  • SHOO $33.16
  • Analyst Decision
  • OCUL Strong Buy
  • SHOO Buy
  • Analyst Count
  • OCUL 9
  • SHOO 7
  • Target Price
  • OCUL $22.13
  • SHOO $30.33
  • AVG Volume (30 Days)
  • OCUL 3.2M
  • SHOO 1.7M
  • Earning Date
  • OCUL 11-13-2025
  • SHOO 11-06-2025
  • Dividend Yield
  • OCUL N/A
  • SHOO 2.52%
  • EPS Growth
  • OCUL N/A
  • SHOO N/A
  • EPS
  • OCUL N/A
  • SHOO 1.28
  • Revenue
  • OCUL $56,664,000.00
  • SHOO $2,319,527,000.00
  • Revenue This Year
  • OCUL N/A
  • SHOO $11.57
  • Revenue Next Year
  • OCUL $18.87
  • SHOO $10.13
  • P/E Ratio
  • OCUL N/A
  • SHOO $26.13
  • Revenue Growth
  • OCUL N/A
  • SHOO 7.97
  • 52 Week Low
  • OCUL $5.79
  • SHOO $19.05
  • 52 Week High
  • OCUL $13.85
  • SHOO $49.12
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 41.98
  • SHOO 62.18
  • Support Level
  • OCUL $10.85
  • SHOO $32.96
  • Resistance Level
  • OCUL $11.77
  • SHOO $34.95
  • Average True Range (ATR)
  • OCUL 0.72
  • SHOO 0.95
  • MACD
  • OCUL -0.16
  • SHOO -0.13
  • Stochastic Oscillator
  • OCUL 28.63
  • SHOO 48.83

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About SHOO Steven Madden Ltd.

Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.

Share on Social Networks: